NEW YORK (TheStreet) -- Sanofi reportedly held talks with Abbott Laboratories , Mylan and private equity firms over the possible sale of a $8.5 billion portfolio of mature drugs, according to an internal document seen by Reuters.
The pharma sector in India is reeling after the National Pharmaceutical Pricing Authority said it's capping prices on about 100 drugs to treat diabetes and heart disease. And the company that could suffer most isn't India-based.
Capping a 20-year effort to develop the world's first dengue fever vaccine, Sanofi has come through with positive results from a sweeping Phase III trial, but its candidate is not quite a panacea for the often deadly disease.
Below are the top drug manufacturers-major stocks on the NYSE in terms of dividend yield.
AstraZeneca PLC (NYSE: AZN) has a dividend yield of 5.00%. AstraZeneca's shares closed at $74.72 on Thursday.
GlaxoSmithKline plc (NYSE: GSK) has a...